What's new in IDIS/Web:

 • New Drugs

 • New Diseases

 • Drug Name/Code Changes

 • FDA Approval Packages

 • Black Box Warnings

 • Advisory Committee Meetings

 • Priority Clinical Practice Guidelines

 • Continuing Education Articles

 

IDIS Training Tools

 

Stay Connected:

 • IDIS on Facebook

 • Join Our Update Lists

 • CAMIPR

 • Monthly Update Information

 


Email: idis@uiowa.edu


Drug Information Resources

IDIS Logo   IDIS Monthly Update Information - June 2011

NEW DRUG TERM
AMG-221
ARQ-197
BLETILLA STRIATA
CARBON BEADS
CBP-501
GSK-461364
MKC-1106-MT
NKTR-118
PI-2301
REVACEPT
RLY-5016
SOLITHROMYCIN
SU-14813
TD-1211
TH-302

CODE
68200443
10120981
92510280
92000367
10120985
10120984
10120636
56120095
14000079
20120679
40180098
8121227
10120982
56120094
10120983


NEW DISEASE TERM
INTOLERANCE, FRUCTOSE

CODE
271.2


DRUG NAME/CODE CHANGES

OLD TERM & CODENEW TERM & CODE
E-5555 20120676ATOPAXAR 20120676
ITF-2357 10120968GIVINOSTAT 10120968
LY-450139 44100087SEMAGACESTAT 44100087
TKI-258 10120887DOVITINIB 10120887


FDA APPROVAL PACKAGES

Article Numbers 656978-656993: Vandetanib Tablets, FDA Approval Package for NDA 022405. FDA Approval Package 2011.

Article Numbers 656164-656177: Roflumilast, Daliresp Tablets, FDA Approval Package for NDA 022522. FDA Approval Package 2011.

Article Numbers 656149-656163: Belimumab, Benlysta, FDA Approval Package for BLA 125370. FDA Approval Package 2011.


BLACK BOX WARNINGS

Article Number 656999: Azilsartan Medoxomil: FDA Black Box Warning. 2011.

Article Number 656998: Vandetanib: FDA Black Box Warning. 2011.

Article Number 656997: Terbutaline: FDA Black Box Warning. 2011.

Article Number 656996: Ipilimumab: FDA Black Box Warning. 2011.

Article Number 656995: Toremifene: FDA Black Box Warning. 2011.

Article Number 656994: Vilazodone: FDA Black Box Warning. 2011.


FDA ADVISORY COMMITTEE MEETINGS

Article Numbers 657188-657193: Endocrinologic and Metabolic Drugs Advisory Committee Meeting, May 19, 2011. FDA Advisory Committee 2011.

Article Numbers 657181-657187: Joint Meeting of the Nonprescription Drugs Advisory Committee and the Pediatric Advisory Committee, May 17-18, 2011. FDA Advisory Committee 2011.

Article Numbers 657173-657180: Joint Meeting of the Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, May 2, 2011. FDA Advisory Committee 2011.

Article Numbers 656882-656887: Antiviral Drugs Advisory Committee Meeting, April 28, 2011. FDA Advisory Committee 2011.

Article Numbers 656876-656881: Antiviral Drugs Advisory Committee Meeting, April 27, 2011. FDA Advisory Committee 2011.

Article Numbers 656868-656875: Oncologic Drugs Advisory Committee Meeting, April 12, 2011. FDA Advisory Committee 2011.

Article Numbers 656859-656867: Vaccines and Related Biological Products Advisory Committee Meeting, April 6-7, 2011. FDA Advisory Committee 2011.


PRIORITY CLINICAL PRACTICE GUIDELINES

Article Number 657194: Anonymous. NICE Technology Appraisal Guidance #220: Golimumab for the Treatment of Psoriatic Arthritis. NICE Technol Appraisal Guid 2011.

Article Number 656478: Anonymous. NICE Technology Appraisal Guidance #222: Trabectedin for the Treatment of Relapsed Ovarian Cancer. NICE Technol Appraisal Guid 2011.

Article Number 656477: Anonymous. NICE Technology Appraisal Guidance #221: Romiplostim for the Treatment of Chronic Immune (Idiopathic) Thrombocytopenic Purpura. NICE Technol Appraisal Guid 2011.

Article Number 656475: Anonymous. NICE Technology Appraisal Guidance #219: Everolimus for the Second-Line Treatment of Advanced Renal Cell Carcinoma. NICE Technol Appraisal Guid 2011.

Article Number 656474: Anonymous. NICE Technology Appraisal Guidance #218: Azacitidine for the Treatment of Myelodysplastic Syndromes, Chronic Myelomonocytic Leukaemia and Acute Myeloid Leukaemia. NICE Technol Appraisal Guid 2011.

Article Number 656473: Anonymous. NICE Technology Appraisal Guidance #217: Donepezil, Galantamine, Rivastigmine and Memantine for the Treatment of Alzheimer'S Disease. NICE Technol Appraisal Guid 2011.

Article Number 656469: Anonymous. Full Guideline. Ovarian Cancer: The Recognition and Initial Management of Ovarian Cancer (Ref Art 656469-656472). NICE Clin Guidel 2011.

Article Number 656465: Anonymous. Full Guideline. Lung Cancer: The Diagnosis and Treatment of Lung Cancer. NICE Clinical Guideline No. 121 (Ref Art 656465-656468). NICE Clin Guidel 2011.

Article Number 656461: Anonymous. Full Guideline. Psychosis with Coexisting Substance Misuse: Assessment and Management in Adults and Young People. NICE Clinical Guideline No. 120 (Ref Art 656461-656464). NICE Clin Guidel 2011.


CONTINUING EDUCATION ARTICLES

Article Number 657384: Rhoney D H. Cost and Resource Allocation Issues in Managing Hyponatremia: The Pharmacist's Role (0.25 CEU) [ IDIS Note: The 2.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 657381-657384]. Pharmacotherapy 2011, 31:25S-30S.

Article Number 657383: Human T. Current Therapeutic Options for Hyponatremia: Indications, Limitations, and Confounding Variables (0.25 CEU) [ IDIS Note: The 2.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 657381-657384]. Pharmacotherapy 2011, 31:18S-24S.

Article Number 657382: Schrier R W. The Science Behind Hyponatremia and Its Clinical Manifestations (0.25 CEU) [ IDIS Note: The 2.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 657381-657384]. Pharmacotherapy 2011, 31:9S-17S.

Article Number 657381: Patterson J H. The Impact of Hyponatremia (0.25 CEU) [ IDIS Note: The 2.5 Hours of CE Credit is for All Articles in this Issue, Article Numbers 657381-657384]. Pharmacotherapy 2011, 31:5S-8S.

Article Number 657377: Baribeault D, Auerbach M. Iron Replacement Therapy in Cancer-Related Anemia (0.15 CEU). Am J Health-Syst Pharm 2011, 68:S4-S14.

Article Number 656593: Anonymous. Drugs for Treatment of ADHD (0.2 CEU). Treat Guidel Med Lett 2011, 9:23-28.

Article Number 656094: Cada D J, Levien T L, Baker D E. Acetaminophen Intravenous (0.15 CEU). Hosp Pharm 2011, 46:273-282.


College of Pharmacy